Logos Global Management LP Spring Works Therapeutics, Inc. Transaction History

Logos Global Management LP

  • $1.07 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$36.14 - $51.99 $3.98 Million - $5.72 Million
-110,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$22.98 - $48.57 $2.53 Million - $5.34 Million
110,000 New
110,000 $4.62 Million
Q1 2020

May 15, 2020
SELL
$20.44 - $41.21 $2.75 Million - $5.54 Million
-134,397 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$17.74 - $39.52 $2.38 Million - $5.31 Million
134,397 New
134,397 $5.17 Million

Others Institutions Holding SWTX

# of Institutions
226
Shares Held
68.1M
Call Options Held
64.7K
Put Options Held
150K
View Full List

About SpringWorks Therapeutics, Inc.

SWTX Quotes by TradingView
  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.09B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email